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Abstract 
 
Pigment dispersion syndrome can lead to pigmentary glaucoma (PG), a poorly understood condition of 
younger, myopic eyes with fluctuating, high intraocular pressure (IOP). The absence of a model similar 
in size and behavior to human eyes has made it difficult to investigate the pathophysiology of IOP, 
pigment and phagocytosis. Here, we present a porcine ex vivo model that recreates the features of PG 
consisting of intraocular hypertension, pigment accumulation in the trabecular meshwork and failure of 
phagocytosis. In in vitro and ex vivo eye perfusion cultures we found that the trabecular meshwork (TM) 
cells that regulate outflow form of actin stress fibers, have a decreased phagocytosis and increased 
migration. Gene microarray and pathway analysis suggested key roles of RhoA and tight junctions in 
regulating the TM cytoskeleton, motility, and phagocytosis thereby providing new targets for future PG 
therapy.  
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Introduction 
Pigmentary glaucoma (PG) is a form of secondary open angle glaucoma in myopic eyes that affects 
patients in their 30s; individuals often experience a high, fluctuating intraocular pressure (IOP) with an 
increased resistance to nonsurgical treatment compared to primary open angle glaucoma​1,2​. In addition 
to a baseline dispersion of pigment, pigment showers can be triggered by physical activity or eye 
movements in some subjects but often remain asymptomatic, making this condition particularly vexing. 
First described by Sugar and Barbour in 1949​3​, the clinical hallmark of pigment release is readily 
apparent with transillumination of the mid-peripheral iris (Fig. 1), deposition of pigment on the corneal 
endothelium (Krukenberg spindle) and in the trabecular meshwork (TM)​4​ yet the pathogenesis remains 
poorly understood. Although the amount of pigment granules in the aqueous humor is correlated to 
IOP​5​, a simple physical obstruction to outflow does not appear to be the cause of increased IOP. 
DBA/2J​6​ and Col18a1(-/-) mice​7 ​ have been used as models of PG but their shortcomings are a mixed 
mechanism form of both angle closure and pigment dispersion​6​ and lack of ocular hypertension​7​, 
respectively. Rodent models also lack the size and multilayered architecture that TM has in larger 
mammals​8​. 
Our prior work took advantage of the availability of pig eyes and an anatomy of the angular aqueous 
plexus ​9​ that matches several features of the human outflow tract ​10–13​; we established gene transfer ​12,14​, 
modeled segmental outflow​11,15,16​ and created a microincisional angle surgery system​17–19 ​. 
We hypothesized that pigment dispersion in perfused pig eyes would cause TM failure with an 
increased IOP. The aim of this study was to develop a standardized and accessible PG model that allows 
to study TM function and signal pathway changes to identify new treatment targets.  
  
Results 
We developed a porcine eye model of PG by replicating the clinical features in human patients: 
individuals with PG have a higher concentration of pigment granules in the aqueous humor​5​, inside of 
TM cells​20–22​, and experience a migration of these cells​20,21​. 
Pigment granules lack cytotoxicity to primary TM cells. ​We produced pigment granules of 1.03±0.11 
micron that were similar to pigment in human pigmentary glaucoma by subjecting porcine iris pigment 
epithelium to freeze-thaw cycles. Stocks could be kept ​at a concentration of 4.3x10​9​ particles/ml for up 
to 1 month ​ (Fig. 1A)​. Primary TM cells obtained from freshly prepared TM exhibited the characteristic 
spindle-shaped morphology and were phagocytotically active. They expressed TM specific markers, 
MGP, AQP1 and alpha-SMA ​(Fig. 1B)​.  
The cytotoxicity of pigment granules was evaluated by flow cytometry and immunostaining using 
calcein AM and PI co-labelling. ​Viable TM cells can convert non-fluorescent calcein AM to green 
fluorescent calcein by intracellular esterase, but do not allow propidium iodide (PI) entrance or binding 
of nucleic acids​23​. ​Pigment granules at ​1.67 x 10​7​ particles/ml neither increased the percentage of PI 
labelled apoptotic or dead cells ((0.00± ​0.00)%​ in the pigment group vs (0.27±​0.07)% in the normal 
control, P>0.05​) nor decreased the percentage of calcein labelled viable cells ((84.90±​3.87)%​ in the 
pigment group compared to (84.57±​3.00)% in the normal control, P>0.05​)​ (Fig. 1C)​. 
 
Figure 1: Pigment generation and in vitro exposure to pigment dispersion.​ In the human eye with pigment 
dispersion, pigment and eventually stroma is lost in the midperiphery of the iris (transillumination, A, left). 
Similar pigment granules of can be generated by exposing an explanted pig iris to freeze-thaw cycles (A, middle 
and right). Granules had an even size of 1.03 0.11 micron (A, right, hemocytometer). Isolated primary±  
trabecular meshwork (TM) cells from pig eyes (B, left to right) displayed the characteristic morphology, 
phagocytotic activity (fluorescent microspheres) and immunostaining pattern of TM specific markers, MGP, 
AQP1 and alpha-SMA (B, right). ​Exposure to to pigment ​did not change the percentage of viable cells ((84.90±
3.87)%​ in the pigment group compared to (84.57 3.00)% in the normal control, P>0.05​) or PI-positive, dead or±  
apoptotic cells (C).  
Pigment elevates intraocular pressure.​ ​Eight left-right matched porcine anterior segment pairs were 
randomly assigned to the pigment or the control group, respectively. Similar baseline IOPs were 
established for 72 hours (11.80±0.78 mmHg vs 11.64±0.51 mmHg, ​P​ = 0.872), followed by 180 hours of 
pigment exposure at a concentration of 1.67x10​7 ​ particles/ml, or a sham treatment with normal 
tissue-culturing medium. The control group did not have any significant change of IOP throughout the 
experiment (all ​P​ >0.05). In contrast, pigment resulted in an IOP elevation that became significantly 
higher at 24 hours, peaked at 96 hours at 23.0±6.0 mmHg and persisted at an IOP 75% above the 
baseline of 11.5±0.8 mmHg (all ​P​ <0.05, compared to group average baseline). Pigment dispersion eyes 
had a significantly greater IOP fluctuation than controls (1.78±0.16 vs 0.83±0.05, ​P​ <0.001), indicating 
different IOP responses of individual eyes to pigment treatment existed ​(Fig. 2)​. 
 
Figure 2. IOP elevation following pigment dispersion.​ ​IOP of perfused anterior segments starting to increase 
after 48 hours (P=0.026) and persisted for the remainder of the study (all P<0.05). IOP fluctuation in the 
pigment group was significantly larger than in the paired controls (P<0.001). A media change occurred after the 
96 hour time point. 
Lysosome and phagosome activated by pigment. ​Anterior segments of control eyes presented with a 
normal TM consisting of the uveal , corneoscleral, and cribriform meshwork immediately adjacent to 
the inner wall of Schlemm's canal like segments of the angular aqueous plexus ​(Fig. 3A)​. Only 
occasional, scattered pigment was seen that was intracellular ​(Fig. 3I, red arrowhead) ​. In contrast, 
pigment dispersion eyes contained numerous TM cells with intracytoplasmic pigment granules, 
including enlarged cells that were protruding into elements of the downstream outflow tract​ (Fig. 3B, C, 
F, G, J, K, read arrowheads)​. There was no evidence of collapse of intertrabecular spaces or a physical 
pigment obstruction the TM or collector channels ​(Fig. 3B and C) ​. Ultrastructurally, pigment induced the 
activation of lysosomes and phagosomes both in vitro and ex vivo ​(Fig. 3K and L, blue arrowheads)​. 
Numerous pigment granules appeared ingested and at different stages of hydrolysis by secondary 
lysosomes ​(Fig. 3K L)​. A swollen and distended endoplasmic reticulum could also frequently be seen in 
these eyes ​(Fig. 3J, K and L, yellow arrowheads)​.  
 Figure 3. Ultrastructure and histology of the trabecular meshwork (TM). ​The TM consisted of three 
characteristic layers: the uveal meshwork (dashed line box, Figure 3A), the corneoscleral meshwork (solid line 
box, Figure 3A) and the juxtacanalicular meshwork (solid line, Figure 3A), adjacent to the inner wall of 
Schlemm's canal (SC) (Figure 3A, black stars). The outer layers were phagocytotically active. Pigment granules 
were located within cells and around the nucleus in the ex vivo model (Figure 3B and 3C, red arrows) and in 
vitro (Figure 3D, red arrows). Transmission electron microscopy showed occasional pigment in normal TM 
(Figure 3E and 3I, red arrows), and a larger number in the inner TM layers (Figure 3F and Figure 3J, red arrows), 
the outer TM layers (Figure 3G and 3K, red arrows) and in primary TM cells (Figure 3H). Pigment hydrolysis in 
different phagolysosome stages (Figure 3K and 3L, Blue arrows) and endoplasmic reticulum (Figure 3J and 3L, 
Yellow arrows) were also seen in vitro and ex vivo. 
 
Declining phagocytosis, motility and cytoskeleton disruption. ​The reorganization of the cytoskeleton​24​, 
decrease of phagocytosis​25,26​ and increase of motility​20,21​, features are closely related to regulation of 
outflow​27​, were three most notable observations in eyes exposed to pigment. Different from the in vitro 
cell body contraction of the dexamethasone treated positive control group ​(Fig. 4 B4, 100 nM) ​, pigment 
did not cause a significant morphological change at day 1 and 7 in primary TM cells ​(Fig. 4 B2-3) ​.  
We used F-actin to label the cytoskeleton of TM cells. The earliest changes of the F-actin cytoskeleton 
by the pigment treatment included polymerization of F-actin microfilaments and formation of stress 
fiber bundles ​(white arrowheads, Fig. 4B2 and 3)​. These stress fibers further polymerized and became 
long, thick, filamentous bundles at day 7 ​(Fig. 4B3) ​. Similarly, 100 nM dexamethasone also induced thick 
F-actin stress bundles​ (Fig. 4B4, write arrowheads)​ at day 7, but with many nest-like actin networks, not 
the cross-linked actin networks (CLANs) as reported in human TM cells​28​. Consistent with in vitro 
findings, F-actin microfilaments in normal TM flat-mounted tissue samples showed weak, spot-like or 
segmental stainings​ (Fig. 4C1 and 2)​, contrasting the thick, bundle-like, continuous stress fibers in the 
pigment group ​(Fig. 4C3 and 4)​. 
 
 
Figure 4. TM cytoskeletal changes induced by pigment.​ Primary TM cells exhibited typical spindle-like shapes 
(Figure 4A1) and did not show significantly morphological changes when exposed to pigment granules on day 1 
(Figure 4A2) and day 7 (Figure 4A3). In contrast, dexamethasone used in positive control eyes induced a cell 
contraction by day 7 (Figure 4A4). F-actin, representative of cytoskeletal changes had fine, feather-like 
microfilaments cytoplasm of negative control TM cells (white arrows arrowheads, Figure 4B1). Pigment 
induced polymerization of actin filaments on day 1 (red arrowheads, Figure 4B2) and became long, thick, stress 
fibers on day 7 (red arrowheads, Figure 4B3). Dexamethasone induced similarly thick actin bundles on day 7 
(red arrowheads, Figure 4B4), but with nest-like actin filaments (red star, Figure 4B4) rather than the 
cross-linked actin networks reported in human TM cells. The F-actin cytoskeleton of flat-mounted normal TM 
tissue showed weak and segmental structures (Figure 4C1-4C2), in contrast to thick, continuous stress fibers in 
the pigment group (Figure 4C3-4C4). 
In vitro phagocytosis was measured by flow cytometry. Normal primary TM cells readily phagocytozed 
carboxylate-modified green-yellow microspheres. In contrast, cells exposed to pigment had a 5.17 fold 
decreased uptake (Fig. 5A; controls: 48.7±2.17%, pigment dispersion eyes 9.4​±​4.2%, P<0.001). We also 
developed a semiquantitative method to measure the ex vivo TM phagocytosis. Carboxylate-modified 
microspheres were perfused into the anterior chambers to be phagocytosed by TM cells in situ. 
Fluorescent intensity could be observed with an epifluorescence equipped dissecting microscope. The 
raw TM fluorescent intensity in the control group was 3.4×10​7​±​4.5×10​6​, significantly higher than that of 
the pigment group 2.2×10​7​±​2.1×10​6 ​ ​(Fig. 5B, ​P​ =0.020) ​. 
 Figure 5. TM phagocytosis.​ In vitro TM phagocytosis was quantified with flow cytometry. Normal primary TM 
cells phagocytose fluorescent microspheres, but pigment dispersion have a 5.17-fold reduce uptake 
48.73±2.17% versus 43±4.2%, P<0.001 (A). Ex vivo TM phagocytosis was quantified in a similar fashion but by 
measuring fluorescence of inverted anterior segments instead. Compared to controls, fluorescence was much 
lower (3.4x10​7 ​±4.5x10​6 ​versus 2.2x10​7​±2.1x10​6​, P= 0.020; **= P<0.01, ***= 0.001). 
 
We also quantified the cell-matrix​29​ and cell-cell adhesion​30​. Confluent TM monolayers that received 
pigment or vehicle treatment were subjected to trypsinization to measure the cell-matrix adhesion. The 
numbers of TM cells per visual field showed no significant difference between the two groups before 
trypsinization (230.00±5.51 in the pigment group versus 244.33±6.39 in controls, ​P​ =0.810). More TM 
cells in the pigment group started to contract, show shrinkage of the cell body, and detach after 
trypsinization. The remaining TM cells in the pigment group were significantly less than that of the 
control at the 2 minute ((173.33±10.81) vs (205.00±1.53), ​P​ =0.038) and 5 min mark (112.33±11.30 vs 
158.67±6.94, ​P​ =0.010)​ (Fig. 6, left band)​. For the cell-cell adhesion assay, confluent TM monolayers 
received pigment or vehicle treatment, were then scraped, digested, and counted. The ratio of cell 
aggregates to total single cells in the pigment group was slightly higher than the control, but not 
statistically different (Fig. 6,​48.95​±​0.06 versus 43.30​±​0.04, ​P​ =0.462)​. 
Cell migration was assessed by the numbers of cells which migrated into six-well plate from glass slides 
that were fully pre-populated with a TM monolayer. An average of ​54583​±​8718 TM cells migrated onto 
the six-well plate after 10 days of pigment treatment, in contrast to 33000±5500 cells in the control 
group, however no statistical difference was found (​P ​ =0.078). 
 Figure 6. Cell adhesion and migration. ​Cell-matrix adhesion was quantified by trypsinization assay. Conflent 
TM monolayers were received either pigment or sham treatment, then were subjected to trypsinization. 
Number of TM cells per visual field showed no statistical difference at the baseline ((230.00±5.51) in the 
pigment group vs 244.33±6.39 in the control, P=0.810). TM cells treated by pigment were more sensitive to 
trypsinization and easier to detach than that of the control. The remaining TM cells were significantly less at 
the 2 minute ((173.33±10.81) vs (205.00±1.53), P = 0.038) and the 5 minute((112.33±11.30) vs (158.67±6.94), ​P 
= 0.010), compared to the control (Figure 6, left band). ​Cell migration​ was quantified by the numbers of TM 
cells migrating from the glass slide pre-populate​d by TM monolayer into six-well-plate. Compared to 
33000​±​5500 in the control group, pigment treatment increased the average numbers of migrating TM cell to 
54583.33 ​±​8718.20 after 10 days, but no statistical difference was found ( ​P​ =0.231) (Figure 6, right band). * and 
** represent P<0.05, and 0.01, respectively. 
 
Pigment changes pathways of cellular movements, phagocytosis and aqueous outflow. ​Three TM 
samples from each group were submitted for Affymetrix Gene Microarray. A total of 24,123 ​porcine 
genes were analyzed, of which 691 were upregulated ​(red dots in volcano plot Fig. 7A and red lines in 
heatmap Fig. 7B)​ and 332 were downregulated ​(green dots in volcano plot in Fig. 7A and green lines in 
heatmap Fig. 7B)​ (​Supplemental Table 1​) more than 1.5 fold with statistical significance after pigment 
treatment (​P​ <0.05). 
 Figure 7: Differential gene expression by pigment treatment.​ Three TM samples from eyes that had a 
confirmed intraocular pressure elevation phenotype were compared to controls using the Affymetrix Gene 3' 
IVT Microarray. A total of 24,123 porcine genes were hybridized, of which 691 were upregulated (red dots in 
volcano plot and red lines in heatmap) and 332 were downregulated (green dots in volcano plot and green 
lines in heatmap) by more than 1.5 fold.  
After excluding 239 porcine genes with unclear biological functions, 784 genes ​(Supplemental Table 2) 
were mapped in our pathway analysis to 16 distinct signal pathways that related to (1) cellular 
movement: cell adhesion, diapedesis and migration, (2) endocytosis and phagocytosis, (3) aqueous 
outflow facility, (4) oxidative stress and endoplasmic reticulum stress, and (5) TM extracellular matrix 
remodelling ​(Fig. 8)​. RhoA signaling, the pivotal pathway that regulates the TM actin cytoskeleton was 
initialized by pigment treatment by a complex consisting of the insulin growth factor (IGF), the type 1 
insulin-like growth factor receptor (IGF-IR) and the lysophosphatidic acid receptor (LPAR) in the cell 
membrane, differing from that of TGFβ and its receptors induced-RhoA activation in POAG. Beside the 
direct inhibition of tight junction formation by RhoA activation, upregulation of rhophilin Rho GTPase 
binding protein (RHPN) also promoted the reorganization of TM actin cytoskeleton which negatively 
affected on tight junction protein 2/zonula occludens-associated nucleic acid binding protein complex, 
thus indirectly inhibit TM tight junction and clathrin, caveolar or Fcγ Receptor-mediated endocytosis 
and phagocytosis. Activation of RhoA signaling also enhanced myosin/MYBPH-mediated actin 
polarization, stress fiber formation and TM contractility which further affected to TM motility.  
 Figure 8. Intracellular signal transduction by pigment treatment. ​After exclusion of 239 genes with unknown 
functions, the rest of 784 differentially expressed genes were mapped by Ingenuity Pathway Analysis to 16 
distinct signal pathways. RhoA signaling initialized by a complex consisting of the insulin growth factor (IGF), 
the type 1 insulin-like growth factor receptor (IGF-IR) and the lysophosphatidic acid receptor (LPAR) acts the 
central role. Activation of RhoA signaling inhibited tight junction protein 2/zonula occludens-associated nucleic 
acid binding protein complex (TJP2/ZONAB) mediated tight junction formation directly or through adjusting 
actin cytoskeleton reorganization by rhophilin Rho GTPase binding protein 2. Disruption of tight junction 
formation reduced the clathrin, caveolar or Fcγ receptor-mediated endocytosis and phagocytosis. Activation 
of RhoA signaling also promoted the stress fiber formation and TM contraction by myosin/MYBPH, thus further 
affected on TM motility. Additionally, TM motility by pigment treatment was regulated by a set of chemokine 
ligands (CCL21/CCL24 and CXCL12/CXCL13) on the cell membrane and their effectors in cytoplasm 
(Wiskott-Aldrich syndrome protein). 
Additionally, the change of TM motility by pigment treatment can also be achieved through 
upregulation of a set of chemokine ligands (CCL21/CCL24 and CXCL12/CXCL13) in cell membrane and 
Wiskott-Aldrich syndrome protein in ​ ​cytoplasm. Key genes, signal pathways are summarized in ​Table 1 
while their upstream regulators are listed in ​Supplementary Table 2​. 
 Discussion 
In this study, we developed an ex vivo model for pigmentary glaucoma (PG) to study TM function and 
signal pathway changes in order to identify new treatment targets for this common form of secondary 
glaucoma. Pig eyes developed the same hypertensive IOP phenotype and histological changes of human 
PG​20,21,31,32​ when pigment was added to mimic pigment dispersion in patients. These are normally 
released from iris pigment epithelium by iridozonular contact and pupillary movement ​33​. We developed 
a freeze-thaw method​34​ to maintain epitopes and avoid chemicals and applied them to this structure. 
These pigment granules are similar to pigment in pigment dispersion, have a typical ovoid or circular 
shape with a mean size of ​1.03​±​0.11 microns, are phagocytosed by TM cells and do no​t cause a physical 
obstruction of intertrabecular spaces​34​. As discussed in the following, these results suggest that the 
cause of high IOP in PG includes a reduced phagocytosis, stress fiber formation, and cell migration.  
We isolated primary porcine TM cells to validated our ex vivo studies. These TM cells displayed 
the typical TM markers seen in human TM cells and readily phagocytozed particulate matter of similar 
size. Unchanged viability of the cells with a complete lack of cytotoxicity or induction of apoptosis when 
exposed to pigment dispersion convinced us to proceed with the ex vivo studies.  
IOP started to diverge in eyes with continuous pigment dispersion at 48 hours and remained at a 
constant level thereafter. These eyes also displayed a larger range of IOPs when compared to controls, 
an observation that matches pigmentary glaucoma in human patients. The IOP elevation of 10 mmHg 
above baseline is within the range seen in a clinical setting, considerably less acute and high compared 
to angle closure models, thereby realistically reflecting the most common phenotype.  
The ultrastructure and histological examination matched studies of human eyes. Most 
importantly, there was no physical obstruction to outflow but rather a relatively modest deposition of 
pigment within the TM and its cells. In anterior segments with pigment diffusion, TM cells were busy 
with phagocytosis and breakdown of ingested pigment granules. The TM cytoskeleton displayed stress 
fibers with polymerization of F-actin microfilaments. Different from the formation of cross-linked actin 
networks in other forms of glaucoma​35​, for instance, steroid induced glaucoma​28​ and POAG​36​, the stress 
fibers in this model are typically long, thick, bundle-like microfilaments, suggesting distinct TM 
cytoskeletal alterations in PG. Human TM cells can form cross-linked actin networks (CLANs) within 7 
days in steroid-induced ocular hypertension​28,35​. An acute disruption of F-actin was reported in latex 
microbead-induced phagocytic challenge of bovine TM cells​37​. TM cytoskeletal changes that directly 
affect the TM stiffness and outflow facility​38​, have already previously been targeted in glaucoma 
medications: ROCK inhibitors ​39​ and NO donors​40​ relax the TM. In contrast, dexamethasone​41​, TGF-β2​42 
and senescence​43​ result in an increased ECM stiffness and decreased outflow. 
We developed a method for in situ visualization and quantitative analysis of TM phagocytosis. 
TM does not only regulate outflow but also prevents debris from entering the outflow system, 
phagocytoses particulate matter and presents it to the immune system​44​. Phagocytosis was reduced to 
20% in pigment exposed TM cells. This appears to be similar to other secondary open angle glaucomas 
with an increased phagocytosis load, in particular ghost cell glaucoma​45​, and steroid induced 
glaucoma​25​. The cell matrix adhesion decreased while their motility increased. Both are features of 
human PD and cause a decreased TM cellularity over time: migration of TM cells into SC has been 
reported in human PG​20,21​ while the cell-matrix adhesion declined resulting in a reorganization of 
cytoskeletal structures​46 ​. This may explain why the pathology of TM in pigmentary glaucoma is so 
different from that of pigment dispersion syndrome​22​; a limited amount of pigment may cause no harm 
and will be degraded but if a threshold is exceeded, TM cells may migrate off the TM-ECM and 
potentially occlude the intertrabecular space or the downstream outflow tract. Gottanka et al​20​ found 
that SCs in human PG specimens were partly (25%-65%) obstructed by loosely arranged, distended 
cribriform TM cells.  
The changes in intracellular signaling in our model highlight the pivotal role of RhoA and its 
activators IGF/IGF1R/LPAR in the molecular pathogenesis of PG. RhoA plays a central role in the actin 
cytoskeleton organization and cell motility ​47​ and has been observed in other glaucomas​48,49 ​. In our 
model, this differed from the TGFβ induced-RhoA activation in POAG​48,49 ​, suggesting a distinctly 
different mechanism. TM tight junctions are formed by the interaction between actin fibers and tight 
junction proteins. Junctional tightness and distribution influence aqueous outflow facility and adhesion - 
downregulation of CDLN2 may be related to increased cell migration​50​. Activation of RhoA caused a 
disruption of TM tight junctions by modulating actin stress fibers​51,52​. The downregulation of CLDN2 and 
ZO-2 is also seen after steroid exposure ​52​. Normal tight junctions contribute to maintaining cell polarity, 
thereby allowing specialized surface functions such as receptor-mediated phagocytosis and endocytosis. 
Consistent with that we found that clathrin or the caveolar-mediated endocytosis pathways and the 
Fcγ receptor-mediated phagocytosis pathway were all significantly downregulated by the pigment 
exposure. Analysis of of signal pathway alteration in a PG model on such a fine scale may be used to 
pinpoint targets of future focus for research and ultimately therapeutic purposes.  
 
In summary, we developed a PG model that manifested a hypertensive IOP phenotype as well as 
histological and ultrastructural characteristics similar to that of human PG. Pathway analysis revealed 
that activation of RhoA plays a pivotal role in the alteration of TM actin cytoskeleton, tight junction 
formation, phagocytosis, and cell motility which each may be provide a specific target for future PG 
treatment. 
 
 
  
Methods 
Generation of pigment 
Ten fresh pig eyes obtained from a local abattoir (Thoma Meat Market, Saxonburg, PA) were sterilized 
and dissected within 2 hours of sacrifice. After removal of the posterior segment, lens, and ciliary body, 
the anterior segments were saved in plain DMEM for mounting. Irises were collected to produce 
pigment granules. The production of pigment granules employed two-step freeze-thaw cycles. Briefly, 
ten irises in 15 ml PBS were frozen at -80​℃​ for two hours, then thawed in the room temperature. After 
two cycles of freeze-thaw, tissue became fragile and pigment granules were shed from the irises 
through pipetting up and down 100 times with a 3ml Pasteur pipette. Pigment granules were filtered by 
a 70 cell strainer (cat#431751, Corning Incorporated, Durham, NC). After spinning at 3000 rpm for 15mμ  
min, supernatant was discarded and pigment granules were resuspended in 15 ml PBS and centrifuged 
again. Finally, the pellet was resuspended in 4 ml PBS and stored in 4​℃​ for ​up to 1 month to serve ​as a 
stock suspension. 
The concentration of pigment granules was measured by a hemocytometer (cat#1490, Hausser 
Scientific, Horsham, PA). To calculate the size of pigment granules, the stock suspension was diluted 
1000 times and visualized by a phase contrast microscope at 600 magnification (Eclipse TE200-E,×  
Nikon Instruments Inc., Melville, NY). At least 100 particles were measured for each batch of 
production. 
TM primary culture 
TM tissue from fresh pig eye was carefully dissected, sectioned into 0.5 mm​3 ​ pieces, and maintained in a 
37℃ humid CO​2​ incubator with TM medium (OptiMEM (31985-070, Gibco, Life technologies, Grand 
Island, NY) supplemented with 5% FBS and 1% antibiotics (15240062, Thermo Fisher Scientific, 
Waltham, MA). After 100% confluence, the cells were passaged in a 1:3 ratio. 
Primary TM cells were identified by immunostaining with TM specific antibodies. Briefly, the cells were 
fixed by 4% PFA for 1 hour, washed with PBS three times, and incubated with primary an​tibodies at 4℃ 
overnight: goat polyc ​lonal matrix gla protein (MGP) anti​body (1:100 dilution in PBS, sc-32820, Santa 
Cruz, Dallas, Texas), rabbit polyclonal anti ​alpha smooth muscle actin ( SMA) ​(1:100, ab5694, Abcam,α  
Cambridge, MA) and aquaporin 1 (AQP1) antibodies (1:100, Sc-20810, Santa Cruz, Dallas, Texas). After 
three rinses of PBS, donkey-anti-goat Alexa Fluor® 647 (1: 1000, ab150131, Abcam, Cambridge, MA) and 
goat anti-rabbit IgG Superclonal™ secondary antibodies were added for 45 minutes in room 
temperature. Cell nuclei were counterstained by DAPI (D1306, Thermo Fisher Scientific, Waltham, MA). 
Pictures were taken by an upright laser scanning confocal microscope at 400 magnification (BX61,×  
Olympus, Tokyo, Japan). 
Cell viability assay 
Primary TM cells were plated into a six-well-plate at 1 10​5​ cells per well and maintained with TM×  
medium containing pigment granules at 1.67 10​7​ particles/ml. TM medium without pigment served as×  
a control. Medium was changed every 3 days for up to 10 days. Cells were stained with calcein AM (0.3 
µM, C1430, Thermo Fisher, Waltham, MA) and PI (1 µg/ml, P1304MP, Thermo Fisher, Waltham, MA) for 
30 minutes, followed by trypsinization and resuspension into 500 µl PBS for flow cytometry. Viable TM 
cells have intracellular esterase activity which can convert non-fluorescent calcein AM to green 
fluorescent calcein, but not allow red fluorescent PI to pass through the intact cell membrane and bind 
to the cell nucleus​23 ​. Thus, the calcein-labeled TM cells were counted as the viable cells while PI stained 
cells were dead or apoptotic cells. 
Ex vivo pigmentary glaucoma model 
Perfusion model: Fresh pig anterior segments were mounted and perfused with DMEM supplemented 
with 1% FBS and 1% antibiotics as described previously​12,34​. Baseline IOPs were obtained after 72 hours 
and pigment granules diluted with perfusion medium to a concentration of 1.67 10​7 ​ particles/ml were×  
perfused for 180 hours. Normal medium without pigment granules served as a control. IOPs were 
recorded at two minute intervals. 
In vitro model: Primary TM cells treated with pigment containing media were utilized as an in vitro PG 
model and the control group was sham treated. Briefly, 3 10​5​ primary TM cells were plated onto a 60×  
mm dish and maintained with OptiMEM supplemented with 5% FBS and 1% antibiotics for 24 hours and 
pigment granules were then added to the final concentration of 1.67 10​7 ​ particles/ml. Medium was×  
changed every three days. Normal TM medium without pigment served as a control. 
Histology and transmission electron microscopy (TEM) 
Anterior segments from perfusion culture were fixed with 4% paraformaldehyde for 24 hours, paraffin 
embedded, cut to 5 sections, and stained with hematoxylin and eosin for histology​12​. Themμ  
ultrastructures of ex vivo TM tissue and in vitro cell monolayers were evaluated by transmission 
electron microscopy (TEM). Preparation of TEM samples followed a previous protocol with minor 
modification ​53​. Briefly, the samples were pre-fixed with 2.5% glutaraldehyde in 0.05 M cacodylate buffer 
for 24 hours, washed with PBS three times and then postfixed with 1% osmium tetroxide solution 
overnight. After 3 rinses of PBS, samples were dehydrated through an ethanol series (30%, 50%, 70%, 
90% and 100% ethanol, 45 minutes each), followed by embedding in Epon (Energy Beam Sciences, East 
Granby, CT). Epon was exchanged completely every hour for three hours and blocks were cured for 2 
days at 60​°C. ​300 nm sections were obtained by Reichert-Jung Ultra-cut 701701 Ultra Microtome and 
stained with 0.5% Toluidine Blue O Solution (S25613, Thermo Fisher Scientific, Waltham, MA) to choose 
areas of interest. Ultrathin sections (65 nm) were obtained and placed on grids. After staining with 
uranyl acetate and lead citrate, pictures were taken under ​an 80 kV Jeol transmission electron 
microscope (Peabody, MA) at various magnifications. 
Phagocytic activity 
In vitro TM phagocytosis was quantified by percentages of TM cells that had engulfed fluorescent 
microspheres using flow cytometry. Briefly, carboxylate-modified yellow-green fluorescent 
microspheres (final concentration: 5 10​8 ​microspheres/ml, diameter: 0.5 micron, cat# F8813, Thermo×  
Fisher, Waltham, MA) were incubated with the TM cells treated by pigment granules or sham treated 
for 1 hour. Cells were washed with PBS three times, trypsinized, and resuspended into 500 ul PBS for 
FACS analysis. 
TM phagocytosis in situ was quantified by measuring TM fluorescent intensity after perfusion with 
carboxylate-modified yellow-green fluorescent microspheres for 24 hours. Briefly, 0.5 mμ
carboxylate-modified yellow-green fluorescent microspheres at 5 10​8 ​/ml were loaded to the perfusion×  
system for 24 hours. Anterior chambers were washed three times with PBS. TM cells that had engulfed 
microspheres showed bright green fluorescence under a dissecting fluorescence microscope (SZX16, 
Olympus, Tokyo, Japan). ​Images were acquired at a 680 x 510 pixel resolution and a 1/17 second 
exposure.​ The raw TM fluorescent intensity was measured by ImageJ as previously described ​(Version 
1.50i, NIH)​17,54​. 
TM cytoskeleton 
F-actin and alpha SMA were used for assessing the cytoskeletal changes of TM in vitro and ex vivo. Ex 
vivo and in vitro TM samples were fixed by 4% PFA for 1 hour and washed with PBS three times. For 
F-actin staining, the samples were incubated with Alexa Fluor® 488 Phalloidin (1:40 dilution, A12379, 
Thermo Fisher, Waltham, MA) for 30 minutes and counterstained with DAPI. For alpha SMA staining, 
samples were incubated with ​rabbit polyclonal​ anti-alpha SMA antibody at 4​℃ overnight, washed three 
times with PBS, and labeled by ​goat anti-rabbit IgG Superclonal™ secondary antibodies and DAPI 
respectively. Images were acquired under an upright laser scanning confocal microscope at 600×
magnification (BX61, Olympus, Tokyo, Japan). 
TM motility 
Cell-matrix adhesion: cell-matrix adhesion was evaluated using a previous protocol with a minor 
modification ​29​. Confluent TM monolayers treated with pigment granules or sham treated were washed 
with PBS and dissociated with 0.25% trypsin. The changes in cell morphology and adhesion were 
monitored by a phase-contrast microscope at different trypsinization time intervals (0 min, 2 min, and 5 
min). The ratio of “numbers of attached TM cell” to “total TM cells” represents the cell-matrix adhesive 
ability. 
Cell migration:​ ​primary TM cells were plated onto 18 mm​2​ cover glasses (2855-18, Corning Incorporated, 
Durham, NC 27712). After 100% confluency, these cover glasses were transferred to six-well plates and 
maintained in TM medium with or without pigment granules (1.67 x 10​7​ particles/ml). Medium was 
replaced every three days. Cover glasses were removed after ten days. Cells which migrated into each 
well from the cover glass were trypsinized and counted by a hemocytometer. 
Gene microarray, qPCR and pathway analysis 
Anterior segments (n=3 each) from the pigment treated and normal control groups were dissected after 
the ideal IOP phenotypes were obtained. Cells from TM tissues were lysed by Trizol Reagent (15596026, 
Invitrogen, Thermo Fisher, Waltham, MA). The lysates were sent to Genomic Core Facility of University 
of Pittsburgh for quantification control. Amplification and hybridization were performed using 
Affymetrix Porcine 3'IVT Array (900624, Affymetrix, Santa Clara, CA) which contains 23,937 probe sets 
to interrogate 23,256 transcripts in pig representing 20,201 ​Sus scrofa​  genes. The Affymetrix CEL files 
were extracted, normalized, and statistically analyzed by ANOVA using Transcriptome Analysis Console 
(TAC) (Version 3.1, Affymetrix, Santa Clara, CA). The differential gene expression profiles were 
characterized by volcano plots and heatmaps. The default filter criteria were (1) Fold Change (linear) < 
-1.5 or Fold Change (linear) > 1.5, and (2) ANOVA p-value < 0.05. Genes that matched these criteria 
were selected for bioinformatic pathway analysis using Ingenuity Pathway Analysis (Qiagen, Hilden, 
Germany). 
Key gene expression was confirmed by qPCR​55​. Briefly, RNA was extracted and reverse transcribed into 
cDNA by High-Capacity cDNA Reverse Transcription Kit (4368814, Thermo Fisher Scientific, Waltham, 
MA). Quantitative PCR was performed on the StepOnePlus™ Real-Time PCR System (4376600, Thermo 
Fisher Scientific, Waltham, MA) according to the manufacturer’s instructions. 2ul of cDNA (10ng/ul), 
10ul of ​SYBR® Green PCR Master Mix, 4ul of ​primers (1000 nM) and 4ul of water ​were loaded into 
96-well PCR plates. The initial denaturation lasted 10 min at 95°C, and cDNA was amplified for 40 cycles 
through 15 sec. denaturation at 95°C and 1 min. annealing and extension at 65°C. Primer sequences are 
listed in Table 1. 
Statistics 
Data was presented as mean±standard error. Differential gene expression was statistically analyzed by 
TAC (Version 3.1, Affymetrix, Santa Clara, CA). Other quantitative data was processed by One-way 
ANOVA by PASW 18.0 (SPSS Inc., Chicago, IL, USA). Statistical difference was considered significant if 
p<0.05. 
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